Saman Adnan: New Research Explores Readmission Risk in Brain Cancer Patients With VTE
Saman Adnan, USMLE Aspirant, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
“Thrilled to share that our team’s abstract has been published in the journal ‘Blood‘ as part of the ‘67th ASH Annual Meeting Abstracts‘!
As the group leader of this incredible, multi-institutional research group, it has been an absolute privilege to work with my fellow talented co-authors and mentor, Jawad Ahmed.
Working alongside such talented peers from across different institutions has been an incredibly rewarding experience.
Our study, ‘Thirty-day readmission in patients with brain cancer and venous thromboembolism: A nationwide analysis using the national readmissions database,’ looks closely at a highly vulnerable neuro-oncologic population.
Venous thromboembolism (VTE) is a severe, life-threatening complication for brain cancer patients, yet data on what drives early hospital readmissions has been limited.”
Title: Thirty-day readmission in patients with brain cancer and venous thromboembolism: A nationwide analysis using the national readmissions database
Authors: Jawad Ahmed, Muhammad Umer Sohail, Muhammad Asjad Riaz, Jazza Jamil, Ahmad Khan, Saman Adnan, Muskan Kumari, Muhammad Umair Noor, Zain Ali Nadeem, Jay Kakadiya, Fnu Bhuvan

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!